2022更新—2015 NICE指南:成人2型糖尿病的管理(NG.28)

2022-03-31 英国国家卫生与临床优化研究所 NICE官网

2022年3月,英国国家卫生与临床优化研究所 (NICE)更新了2015年版成人2型糖尿病的管理指南。指南涵盖了成人2型糖尿病患者的护理和管理。本次更新,专家小组通过回顾最新证据,主

中文标题:

2022更新—2015 NICE指南:成人2型糖尿病的管理(NG.28)

英文标题:

NICE guideline [NG28]:Type 2 diabetes in adults: management

发布日期:

2022-03-31

简要介绍:

2022年3月,英国国家卫生与临床优化研究所 (NICE)更新了2015年版成人2型糖尿病的管理指南。指南涵盖了成人(≥18岁)2型糖尿病患者的护理和管理。本次更新,专家小组通过回顾最新证据,主要针对连续血糖监测提出了新的指导建议。

点击此处←查看中文译文

相关资料下载:
[AttachmentFileName(sort=1, fileName=2022更新—2015 NICE指南:成人2型糖尿病的管理(NG.28).pdf)] GetToolGuiderByIdResponse(projectId=1, id=7c9a51c002a012e4, title=2022更新—2015 NICE指南:成人2型糖尿病的管理(NG.28), enTitle=NICE guideline [NG28]:Type 2 diabetes in adults: management, guiderFrom=NICE官网, authorId=0, author=, summary=2022年3月,英国国家卫生与临床优化研究所 (NICE)更新了2015年版成人2型糖尿病的管理指南。指南涵盖了成人2型糖尿病患者的护理和管理。本次更新,专家小组通过回顾最新证据,主, cover=https://img.medsci.cn/202241/1648805382491_1608702.png, journalId=0, articlesId=null, associationId=2005, associationName=英国国家卫生与临床优化研究所 , associationIntro=英国国家卫生与临床优化研究所 (NICE,National Institute for Health and Clinical Excellence), copyright=0, guiderPublishedTime=Thu Mar 31 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2022年3月,英国国家卫生与临床优化研究所 (NICE)更新了2015年版成人2型糖尿病的管理指南。指南涵盖了成人(&ge;18岁)2型糖尿病患者的护理和管理。本次更新,专家小组通过回顾最新证据,主要针对连续血糖监测提出了新的指导建议。</span></p> <p><strong><span style="color: #373737;"><a href="https://www.medsci.cn/guideline/show_article.do?id=933eb1c002698966" target="_blank" rel="noopener">点击此处</a>&larr;查看中文译文</span></strong></p>, tagList=[TagDto(tagId=216, tagName=糖尿病), TagDto(tagId=17782, tagName=内分泌科), TagDto(tagId=100585, tagName=成人2型糖尿病)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌, tenant=100), CategoryDto(categoryId=8, categoryName=糖尿病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=216, articleKeyword=糖尿病, articleKeywordNum=6, guiderKeywordId=216, guiderKeyword=糖尿病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5849, appHits=324, showAppHits=0, pcHits=678, showPcHits=5525, likes=2, shares=54, comments=5, approvalStatus=1, publishedTime=Sat Apr 02 15:27:00 CST 2022, publishedTimeString=2022-03-31, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=dajiong, createdTime=Fri Apr 01 17:34:32 CST 2022, updatedBy=6459136, updatedName=艺玮, updatedTime=Fri Jan 05 21:56:37 CST 2024, courseDetails=[], otherVersionGuiders=[OtherVersionToolGuiderDto(projectId=1, id=933eb1c002698966, title=【中文译文】2022更新—2015 NICE指南:成人2型糖尿病的管理(NG.28), enTitle=NICE guideline [NG28]:Type 2 diabetes in adults: management, guiderPublishedTime=Thu Mar 31 00:00:00 CST 2022, createdTime=Wed Sep 28 16:41:36 CST 2022)], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2022更新—2015 NICE指南:成人2型糖尿病的管理(NG.28).pdf)])
2022更新—2015 NICE指南:成人2型糖尿病的管理(NG.28).pdf
下载请点击:
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1210760, encodeId=7d361210e608d, content=都英文,看不懂, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d2f5531172, createdName=ms6000001833964428, createdTime=Wed Apr 13 07:23:26 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219042, encodeId=454c121904282, content=学习学习再学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu May 12 12:38:49 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214765, encodeId=c1c01214e6562, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 19:59:57 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208960, encodeId=e5d812089605d, content=很好!好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75895311122, createdName=148898f3m13(暂无昵称), createdTime=Wed Apr 06 12:08:48 CST 2022, time=2022-04-06, status=1, ipAttribution=)]
    2022-04-13 ms6000001833964428

    都英文,看不懂

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1210760, encodeId=7d361210e608d, content=都英文,看不懂, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d2f5531172, createdName=ms6000001833964428, createdTime=Wed Apr 13 07:23:26 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219042, encodeId=454c121904282, content=学习学习再学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu May 12 12:38:49 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214765, encodeId=c1c01214e6562, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 19:59:57 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208960, encodeId=e5d812089605d, content=很好!好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75895311122, createdName=148898f3m13(暂无昵称), createdTime=Wed Apr 06 12:08:48 CST 2022, time=2022-04-06, status=1, ipAttribution=)]
    2022-05-12 湘雅科教

    学习学习再学习!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1210760, encodeId=7d361210e608d, content=都英文,看不懂, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d2f5531172, createdName=ms6000001833964428, createdTime=Wed Apr 13 07:23:26 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219042, encodeId=454c121904282, content=学习学习再学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu May 12 12:38:49 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214765, encodeId=c1c01214e6562, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 19:59:57 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208960, encodeId=e5d812089605d, content=很好!好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75895311122, createdName=148898f3m13(暂无昵称), createdTime=Wed Apr 06 12:08:48 CST 2022, time=2022-04-06, status=1, ipAttribution=)]
    2022-04-26 su_yi_fei

    很实用

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1210760, encodeId=7d361210e608d, content=都英文,看不懂, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d2f5531172, createdName=ms6000001833964428, createdTime=Wed Apr 13 07:23:26 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219042, encodeId=454c121904282, content=学习学习再学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu May 12 12:38:49 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214765, encodeId=c1c01214e6562, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 19:59:57 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208960, encodeId=e5d812089605d, content=很好!好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75895311122, createdName=148898f3m13(暂无昵称), createdTime=Wed Apr 06 12:08:48 CST 2022, time=2022-04-06, status=1, ipAttribution=)]
    2022-04-06 148898f3m13(暂无昵称)

    很好!好好学习

    0

拓展阅读

世界首例自体再生胰岛移植成功,胰岛素依赖型糖尿病治疗获得突破性进展

国际上首次利用诱导多能干细胞(iPS细胞/iPSC)来源的自体再生胰岛移植,成功治愈胰岛功能严重受损糖尿病的病例报道。

降糖降血脂+减重超28斤;司美格鲁肽可减肥还能治心衰 | 糖尿病前沿荟萃

《医学新视点》持续关注糖尿病领域研究进展,梳理了2024年1月~4月全球权威期刊(IF≥10)发表的507篇糖尿病领域研究。

李平平团队《自然·通讯》:发现巨噬细胞分泌的Galectin-3抑制胰岛素分泌

该研究发现了炎症诱导糖尿病胰岛细胞功能障碍的新机制,为改善细胞功能的药物研发提供新靶点和新策略。

人参降糖秘籍:网络药理学揭秘,实验验证二型糖尿病(T2DM)新疗法!

文章探讨了人参Rk1+Rg5对T2DM的潜在治疗机制。

Cell Discov:殷浩/程新团队成功利用体外再造胰岛组织移植治愈胰岛素依赖型糖尿病获得突破性进展

该研究首次在人体内证实,干细胞来源的再生胰岛组织可长期有效代偿T2D晚期患者的胰岛功能损失,逆转高血糖并实现功能性治愈。

《柳叶刀》子刊:这种科学饮食策略,或可以降低患糖尿病风险!

,高血糖指数和高血糖负荷的饮食与2型糖尿病的发病风险较高有关,同时在体重指数(BMI)较高的个体中,这种关系更密切。

2009 中国糖尿病护理及教育指南

中华医学会糖尿病学分会(CDS,Chinese Diabetes Society) · 2009-10-30

2010CARI 2型糖尿病患者的肾功能评估

澳大利亚肾病指南委员会(CARI,Caring for Australasians with Renal Impairment) · 2010-01-01

2010CARI 2型糖尿病患者中慢性肾脏病的预防和管理

澳大利亚肾病指南委员会(CARI,Caring for Australasians with Renal Impairment) · 2010-01-01

2010 AOA(POA)糖尿病患者眼部健康

美国视觉协会(AOA,American Optometric Association) · 2010-01-01

中国糖尿病医学营养治疗指南 (2010年)

中华医学会糖尿病学分会(CDS,Chinese Diabetes Society) · 2010-01-01

运动与2型糖尿病联合声明

美国糖尿病学会(ADA,American Diabetes Association) · 2010-01-01